(+)-4-PROPYL-9-HYDROXYNAPHTHOXAZINE (PHNO), A NEW DOPAMINOMIMETIC, IN TREATMENT OF PARKINSONISM-Reference-Cited by-同舟云学术

(+)-4-PROPYL-9-HYDROXYNAPHTHOXAZINE (PHNO), A NEW DOPAMINOMIMETIC, IN TREATMENT OF PARKINSONISM

Published:1985-12 Issue:8468 Volume:326 Page:1330-1331
ISSN:0140-6736
Container-title:The Lancet
language:en
Short-container-title:The Lancet

Author:

Stoessl A.Jon,Mak E.,Calne DonaldB.

Publisher

Elsevier BV

Subject

General Medicine

Reference6 articles.

1. Dopamine receptor agonists in the treatment of basal ganglia disorders;Calne;Semin Neurol,1982

2. Pharmacological profile of a novel potent direct-acting dopamine agonist, (+)-4-propyl-9-hydroxynaphthoxazine [(+)-PHNO];Martin;J Pharmacol Exp Ther,1984

3. Parkinsonism. onset, progression and mortality;Hoehn;Neurology,1967

4. Bromocriptine associated with a peripheral dopamine blocking agent in treatment of Parkinson's disease;Agid;Lancet,1979

5. The evaluation of extrapyramidal disease;Duvoisin,1970

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clerodendrum colebrookianum extract mediated synthesis of AgNPs and its effective application as a sustainable catalyst for Oxazine transformation in neat condition and antibacterial activity.;Chemical Physics Impact;2022-12

2. Interaction of the preferential D3 agonist (+)PHNO with dopamine D3-D2 receptor heterodimers and diverse classes of monoamine receptor: relevance for PET imaging;European Journal of Pharmacology;2022-06

3. Medicinal chemistry of oxazines as promising agents in drug discovery;Chemical Biology & Drug Design;2019-10-20

4. Predictive Value of Parkinsonian Primates in Pharmacologic Studies: A Comparison between the Macaque, Marmoset, and Squirrel Monkey;Journal of Pharmacology and Experimental Therapeutics;2018-03-09

5. Neurotoxins and medicinals for the treatment of Parkinson’s disease. Part 2: dopamine receptors and their agonists;Pharmaceutical Chemistry Journal;2005-10